Story perspectives

Trump's AstraZeneca Deal: Medicaid Discounts Amid Tariff Relief

10/14/2025

31 4

Summary

Story summary

President Donald J. Trump announced a deal with AstraZeneca to provide Medicaid discounts in exchange for tariff relief.
AstraZeneca will offer discounts up to 80% via the TrumpRx website, launching in early 2026.
The company will invest $50 billion in U.S. manufacturing, including a Virginia plant.
The deal follows a similar arrangement with Pfizer.
Experts question benefits for patients, noting Medicaid already has low prices and long-term affordability concerns.

1 of 1

Story summary

President Donald J. Trump announced a deal with AstraZeneca to provide Medicaid discounts in exchange for tariff relief.
AstraZeneca will offer discounts up to 80% via the TrumpRx website, launching in early 2026.
The company will invest $50 billion in U.S. manufacturing, including a Virginia plant.
The deal follows a similar arrangement with Pfizer.
Experts question benefits for patients, noting Medicaid already has low prices and long-term affordability concerns.